Medications for Weight Loss (Obesity/Overweight)
Other names: Obesity
See also: sub-topics
Drugs used for Weight Loss (Obesity/Overweight)
The following list of medications are in some way related to or used in the treatment of this condition.
Drug name | Rating | Reviews | Activity ? | Rx/OTC | Pregnancy | CSA | Alcohol |
---|---|---|---|---|---|---|---|
phentermine | 8.7 | 2943 reviews | Rx | ||||
Generic name: phentermine systemic Brand names: Adipex-P, Lomaira, Atti-Plex P Drug class: CNS stimulants, anorexiants For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
topiramate Off-label | 7.4 | 232 reviews | Rx | ||||
Generic name: topiramate systemic Brand name: Topamax Drug class: carbonic anhydrase inhibitor anticonvulsants For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information Off-label: Yes |
|||||||
Adipex-P | 8.9 | 600 reviews | Rx | ||||
Generic name: phentermine systemic Drug class: CNS stimulants, anorexiants For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Wegovy | 6.6 | 228 reviews | Rx | ||||
Generic name: semaglutide systemic Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
semaglutide | 6.5 | 354 reviews | Rx | ||||
Generic name: semaglutide systemic Brand names: Wegovy, Ozempic Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
Ozempic | 6.1 | 55 reviews | Rx | ||||
Generic name: semaglutide systemic Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Topamax Off-label | 6.6 | 68 reviews | Rx | ||||
Generic name: topiramate systemic Drug class: carbonic anhydrase inhibitor anticonvulsants For consumers: dosage, interactions, side effects For professionals: Prescribing Information Off-label: Yes |
|||||||
Mounjaro Off-label | 8.5 | 72 reviews | Rx | ||||
Generic name: tirzepatide systemic Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: Prescribing Information Off-label: Yes |
|||||||
tirzepatide Off-label | 8.3 | 95 reviews | Rx | ||||
Generic name: tirzepatide systemic Brand name: Mounjaro Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph Off-label: Yes |
|||||||
Contrave | 6.6 | 1950 reviews | Rx | ||||
Generic name: bupropion / naltrexone systemic Drug class: anorexiants For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Desoxyn | 10 | 4 reviews | Rx | ||||
Generic name: methamphetamine systemic Drug class: CNS stimulants, anorexiants For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
bupropion Off-label | 7.3 | 51 reviews | Rx | ||||
Generic name: bupropion systemic Drug class: miscellaneous antidepressants, smoking cessation agents For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information Off-label: Yes |
|||||||
Alli | 6.0 | 111 reviews | OTC | ||||
Generic name: orlistat systemic Drug class: peripherally acting antiobesity agents For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
orlistat | 7.4 | 369 reviews | Rx/OTC | ||||
Generic name: orlistat systemic Brand names: Alli, Xenical Drug class: peripherally acting antiobesity agents For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Xenical | 8.4 | 114 reviews | Rx | ||||
Generic name: orlistat systemic Drug class: peripherally acting antiobesity agents For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
phendimetrazine | 8.3 | 151 reviews | Rx | ||||
Generic name: phendimetrazine systemic Brand names: Bontril PDM, Fendique ER Drug class: CNS stimulants, anorexiants For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Saxenda | 7.5 | 1417 reviews | Rx | ||||
Generic name: liraglutide systemic Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
diethylpropion | 8.7 | 156 reviews | Rx | ||||
Generic name: diethylpropion systemic Drug class: CNS stimulants, anorexiants For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Qsymia | 7.7 | 558 reviews | Rx | ||||
Generic name: phentermine / topiramate systemic Drug class: anorexiants For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
methamphetamine | 10 | 5 reviews | Rx | ||||
Generic name: methamphetamine systemic Brand name: Desoxyn Drug class: CNS stimulants, anorexiants For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information |
|||||||
Pregnyl Off-label | 9.0 | 1 review | Rx | ||||
Generic name: chorionic gonadotropin (hcg) systemic Drug class: gonadotropins For consumers: dosage, interactions, side effects For professionals: Prescribing Information Off-label: Yes |
|||||||
bupropion / naltrexone | 6.6 | 2027 reviews | Rx | ||||
Generic name: bupropion / naltrexone systemic Brand name: Contrave Drug class: anorexiants For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
liraglutide | 7.6 | 1751 reviews | Rx | ||||
Generic name: liraglutide systemic Brand name: Saxenda Drug class: incretin mimetics For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
phentermine / topiramate | 7.8 | 682 reviews | Rx | ||||
Generic name: phentermine / topiramate systemic Brand name: Qsymia Drug class: anorexiants For consumers: dosage, interactions, side effects For professionals: AHFS DI Monograph |
|||||||
amphetamine | 10 | 1 review | Rx | ||||
Generic name: amphetamine systemic Brand name: Evekeo Drug class: CNS stimulants For consumers: dosage, interactions, side effects For professionals: Prescribing Information |
|||||||
Frequently asked questions
- Is obesity a major risk factor for Covid-19?
- How do Mounjaro, Wegovy & Ozempic compare for weight loss?
- Does Wellbutrin XL/SR cause weight gain or loss?
- How long does it take to lose weight on Wegovy?
- Does Mounjaro have a $25 coupon available?
- Does Mounjaro work for weight loss?
- Why am I not losing weight on Saxenda?
Topics under Weight Loss (Obesity/Overweight)
- Cellulite (2 drugs)
Alternative treatments for Weight Loss (Obesity/Overweight)
The following products are considered to be alternative treatments or natural remedies for Weight Loss (Obesity/Overweight). Their efficacy may not have been scientifically tested to the same degree as the drugs listed in the table above. However there may be historical, cultural or anecdotal evidence linking their use to the treatment of Weight Loss (Obesity/Overweight).
Learn more about Weight Loss
- How to Calculate Your Body Mass Index (BMI)
- Surgery for Weight Loss: What Are Your Options?
- U.S. Childhood Obesity Epidemic: Treatment and Prevention
- Weight Loss and Diet Pills: Options to Know
- Which Drugs Cause Weight Gain?
Care guides
Symptoms and treatments
Legend
Rating | For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). |
---|---|
Activity | Activity is based on recent site visitor activity relative to other medications in the list. |
Rx | Prescription only. |
OTC | Over-the-counter. |
Rx/OTC | Prescription or Over-the-counter. |
Off-label | This medication may not be approved by the FDA for the treatment of this condition. |
EUA | An Emergency Use Authorization (EUA) allows the FDA to authorize unapproved medical products or unapproved uses of approved medical products to be used in a declared public health emergency when there are no adequate, approved, and available alternatives. |
Expanded Access | Expanded Access is a potential pathway for a patient with a serious or immediately life-threatening disease or condition to gain access to an investigational medical product (drug, biologic, or medical device) for treatment outside of clinical trials when no comparable or satisfactory alternative therapy options are available. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities and/or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved in use in pregnant women clearly outweigh potential benefits. |
N | FDA has not classified the drug. |
Controlled Substances Act (CSA) Schedule | |
---|---|
M | The drug has multiple schedules. The schedule may depend on the exact dosage form or strength of the medication. |
U | CSA Schedule is unknown. |
N | Is not subject to the Controlled Substances Act. |
1 | Has a high potential for abuse. Has no currently accepted medical use in treatment in the United States. There is a lack of accepted safety for use under medical supervision. |
2 | Has a high potential for abuse. Has a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe psychological or physical dependence. |
3 | Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
4 | Has a low potential for abuse relative to those in schedule 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3. |
5 | Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Alcohol | |
---|---|
X | Interacts with Alcohol. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.